Application progress of 7T ultra-high field MRI in diagnosis and treatment of drug-resistant epilepsy

doi:10.3969/j.issn.1672-6731.2023.03.003

Abstract

Abstract: 7T ultra-high field MRI (7T MRI), with its high resolution, high signal-to-noise ratio (SNR) and high contrast, is superior to conventional field intensity MRI in clinical applications such as diagnosis of hippocampal sclerosis (HS) and focal cortical dysplasia (FCD), assisting in the identification of pathological subtypes of the both, locating the scope of surgical excision, and has made progress in the diagnosis and treatment of drug-resistant epilepsy (DRE). This paper aims to review the clinical application value and research progress of 7T MRI in order to promote its application in the field of diagnosis and treatment of epilepsy.

Key words: Drug resistant epilepsy, Magnetic resonance imaging, Review

摘要： 7T 超高场强MRI（简称7T MRI）的高分辨率、高信噪比和高对比度特点，使其在海马硬化和局灶性皮质发育不良诊断、辅助鉴别二者病理亚型、定位手术切除范围等临床应用中优于常规场强MRI，并已在耐药性癫痫病因诊断与治疗中取得进展。本文综述7T MRI 的临床应用价值及研究进展，以推动其在癫痫诊断与治疗领域的应用。

关键词: 耐药性癫痫, 磁共振成像, 综述

GE Yi, CHEN Cong, WANG Shuang, DING Yao. Application progress of 7T ultra-high field MRI in diagnosis and treatment of drug-resistant epilepsy[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2023, 23(3): 161-166.

葛懿, 陈聪, 王爽, 丁瑶. 7T超高场强MRI在耐药性癫痫诊断与治疗中的应用进展[J]. 中国现代神经疾病杂志, 2023, 23(3): 161-166.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2023.03.003

https://journal11.magtechjournal.com/cjcnn/EN/Y2023/V23/I3/161

References

[1] Beghi E. The epidemiology of epilepsy[J]. Neuroepidemiology, 2020, 54:185-191.
[2] Ding D, Zhou D, Sander JW, Wang W, Li S, Hong Z. Epilepsy in China:major progress in the past two decades[J]. Lancet Neurol, 2021, 20:316-326.
[3] Löscher W, Potschka H, Sisodiya SM, Vezzani A. Drug resistance in epilepsy:clinical impact, potential mechanisms, and new innovative treatment options[J]. Pharmacol Rev, 2020, 72:606-638.
[4] Rugg-Gunn F, Miserocchi A, McEvoy A. Epilepsy surgery[J]. Pract Neurol, 2020, 20:4-14.
[5] Wang I, Bernasconi A, Bernhardt B, Blumenfeld H, Cendes F, Chinvarun Y, Jackson G, Morgan V, Rampp S, Vaudano AE, Federico P. MRI essentials in epileptology:a review from the ILAE Imaging Taskforce[J]. Epileptic Disord, 2020, 22:421-437.
[6] Asadi-Pooya AA, Farazdaghi M. Clinical characteristics of MRI-negative temporal lobe epilepsy[J]. Acta Neurol Belg, 2022[.Epub ahead of print]
[7] Téllez-Zenteno JF, Hernández Ronquillo L, Moien-Afshari F, Wiebe S. Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis[J]. Epilepsy Res, 2010, 89:310-318.
[8] Okada T, Fujimoto K, Fushimi Y, Akasaka T, Thuy DHD, Shima A, Sawamoto N, Oishi N, Zhang Z, Funaki T, Nakamoto Y, Murai T, Miyamoto S, Takahashi R, Isa T. Neuroimaging at 7 Tesla:a pictorial narrative review[J]. Quant Imaging Med Surg, 2022, 12:3406-3435.
[9] Hoffmann L, Blümcke I. Neuropathology and epilepsy surgery[J]. Curr Opin Neurol, 2022, 35:202-207.
[10] Steve TA, Gargula J, Misaghi E, Nowacki TA, Schmitt LM, Wheatley BM, Gross DW. Hippocampal subfield measurement and ILAE hippocampal sclerosis subtype classification with in vivo 4.7 tesla MRI[J]. Epilepsy Res, 2020, 161:106279.
[11] Baulac M. MTLE with hippocampal sclerosis in adult as a syndrome[J]. Rev Neurol (Paris), 2015, 171:259-266.
[12] Blümcke I, Pauli E, Clusmann H, Schramm J, Becker A, Elger C, Merschhemke M, Meencke HJ, Lehmann T, von Deimling A, Scheiwe C, Zentner J, Volk B, Romstöck J, Stefan H, Hildebrandt M. A new clinico-pathological classification system for mesial temporal sclerosis[J]. Acta Neuropathol, 2007, 113:235-244.
[13] Pai A, Marcuse LV, Alper J, Delman BN, Rutland JW, Feldman RE, Hof PR, Fields M, Young J, Balchandani P. Detection of hippocampal subfield asymmetry at 7T with automated segmentation in epilepsy patients with normal clinical strength MRIs[J]. Front Neurol, 2021, 12:682615.
[14] Canjels LPW, Backes WH, van Veenendaal TM, Vlooswijk MCG, Hofman PAM, Aldenkamp AP, Rouhl RPW, Jansen JFA. Volumetric and functional activity lateralization in healthy subjects and patients with focal epilepsy:initial findings in a 7T MRI study[J]. J Neuroimaging, 2020, 30:666-673.
[15] Santyr BG, Goubran M, Lau JC, Kwan BYM, Salehi F, Lee DH, Mirsattari SM, Burneo JG, Steven DA, Parrent AG, de Ribaupierre S, Hammond RR, Peters TM, Khan AR. Investigation of hippocampal substructures in focal temporal lobe epilepsy with and without hippocampal sclerosis at 7T[J]. J Magn Reson Imaging, 2017, 45:1359-1370.
[16] Feldman RE, Marcuse LV, Verma G, Brown SSG, Rus A, Rutland JW, Delman BN, Balchandani P, Fields MC. Seven-tesla susceptibility-weighted analysis of hippocampal venous structures:application to magnetic-resonance-normal focal epilepsy[J]. Epilepsia, 2020, 61:287-296.
[17] Coras R, Milesi G, Zucca I, Mastropietro A, Scotti A, Figini M, Mühlebner A, Hess A, Graf W, Tringali G, Blümcke I, Villani F, Didato G, Frassoni C, Spreafico R, Garbelli R. 7T MRI features in control human hippocampus and hippocampal sclerosis:an ex vivo study with histologic correlations[J]. Epilepsia, 2014, 55:2003-2016.
[18] Gillmann C, Coras R, Rössler K, Doerfler A, Uder M, Blümcke I, Bäuerle T. Ultra-high field MRI of human hippocampi:morphological and multiparametric differentiation of hippocampal sclerosis subtypes[J]. PLoS One, 2018, 13:e0196008.
[19] Stefanits H, Springer E, Pataraia E, Baumgartner C, Hainfellner JA, Prayer D, Weisstanner C, Czech T, Trattnig S. Seven-tesla MRI of hippocampal sclerosis:an in vivo feasibility study with histological correlations[J]. Invest Radiol, 2017, 52:666-671.
[20] Tkác I, Andersen P, Adriany G, Merkle H, Ugurbil K, Gruetter R. In vivo 1H NMR spectroscopy of the human brain at 7T[J]. Magn Reson Med, 2001, 46:451-456.
[21] Gonen OM, Moffat BA, Desmond PM, Lui E, Kwan P, O'Brien TJ. Seven-tesla quantitative magnetic resonance spectroscopy of glutamate, γ -aminobutyric acid, and glutathione in the posterior cingulate cortex/precuneus in patients with epilepsy[J]. Epilepsia, 2020, 61:2785-2794.
[22] Hadar PN, Kini LG, Nanga RPR, Shinohara RT, Chen SH, Shah P, Wisse LEM, Elliott MA, Hariharan H, Reddy R, Detre JA, Stein JM, Das S, Davis KA. Volumetric glutamate imaging (GluCEST) using 7T MRI can lateralize nonlesional temporal lobe epilepsy:a preliminary study[J]. Brain Behav, 2021, 11:e02134.
[23] Guerrini R, Barba C. Focal cortical dysplasia:an update on diagnosis and treatment[J]. Expert Rev Neurother, 2021, 21:1213-1224.
[24] Urbach H, Kellner E, Kremers N, Blümcke I, Demerath T. MRI of focal cortical dysplasia[J]. Neuroradiology, 2022, 64:443-452.
[25] Najm I, Lal D, Alonso Vanegas M, Cendes F, Lopes-Cendes I, Palmini A, Paglioli E, Sarnat HB, Walsh CA, Wiebe S, Aronica E, Baulac S, Coras R, Kobow K, Cross JH, Garbelli R, Holthausen H, Rössler K, Thom M, El-Osta A, Lee JH, Miyata H, Guerrini R, Piao YS, Zhou D, Blümcke I. The ILAE consensus classification of focal cortical dysplasia:an update proposed by an ad hoc task force of the ILAE diagnostic methods commission[J]. Epilepsia, 2022, 63:1899-1919.
[26] Blumcke I, Spreafico R, Haaker G, Coras R, Kobow K, Bien CG, Pfäfflin M, Elger C, Widman G, Schramm J, Becker A, Braun KP, Leijten F, Baayen JC, Aronica E, Chassoux F, Hamer H, Stefan H, Rössler K, Thom M, Walker MC, Sisodiya SM, Duncan JS, McEvoy AW, Pieper T, Holthausen H, Kudernatsch M, Meencke HJ, Kahane P, Schulze-Bonhage A, Zentner J, Heiland DH, Urbach H, Steinhoff BJ, Bast T, Tassi L, Lo Russo G, Özkara C, Oz B, Krsek P, Vogelgesang S, Runge U, Lerche H, Weber Y, Honavar M, Pimentel J, Arzimanoglou A, Ulate-Campos A, Noachtar S, Hartl E, Schijns O, Guerrini R, Barba C, Jacques TS, Cross JH, Feucht M, Mühlebner A, Grunwald T, Trinka E, Winkler PA, Gil-Nagel A, Toledano Delgado R, Mayer T, Lutz M, Zountsas B, Garganis K, Rosenow F, Hermsen A, von Oertzen TJ, Diepgen TL, Avanzini G; EEBB Consortium. Histopathological findings in brain tissue obtained during epilepsy surgery[J]. N Engl J Med, 2017, 377:1648-1656.
[27] Young GS, Kimbrell V, Seethamraju R, Bubrick EJ. Clinical 7T MRI for epilepsy care:value, patient selection, technical issues, and outlook[J]. J Neuroimaging, 2022, 32:377-388.
[28] van Lanen RHGJ, Colon AJ, Wiggins CJ, Hoeberigs MC, Hoogland G, Roebroeck A, Ivanov D, Poser BA, Rouhl RPW, Hofman PAM, Jansen JFA, Backes W, Rijkers K, Schijns OEMG. Ultra-high field magnetic resonance imaging in human epilepsy:a systematic review[J]. Neuroimage Clin, 2021, 30:102602.
[29] De Ciantis A, Barba C, Tassi L, Cosottini M, Tosetti M, Costagli M, Bramerio M, Bartolini E, Biagi L, Cossu M, Pelliccia V, Symms MR, Guerrini R. 7T MRI in focal epilepsy with unrevealing conventional field strength imaging[J]. Epilepsia, 2016, 57:445-454.
[30] Wang I, Oh S, Blümcke I, Coras R, Krishnan B, Kim S, McBride A, Grinenko O, Lin Y, Overmyer M, Aung TT, Lowe M, Larvie M, Alexopoulos AV, Bingaman W, Gonzalez-Martinez JA, Najm I, Jones SE. Value of 7T MRI and post-processing in patients with nonlesional 3T MRI undergoing epilepsy presurgical evaluation[J]. Epilepsia, 2020, 61:2509-2520.
[31] Chen C, Xie JJ, Ding F, Jiang YS, Jin B, Wang S, Ding Y, Li H, Jiang B, Zhu JM, Ding MP, Chen Z, Wu ZY, Zhang BR, Hsu YC, Lai HY, Wang S. 7T MRI with post -processing for the presurgical evaluation of pharmacoresistant focal epilepsy[J]. Ther Adv Neurol Disord, 2021, 14:17562864211021180.
[32] Veersema TJ, van Eijsden P, Gosselaar PH, Hendrikse J, Zwanenburg JJ, Spliet WG, Aronica E, Braun KP, Ferrier CH. 7 tesla T2*-weighted MRI as a tool to improve detection of focal cortical dysplasia[J]. Epileptic Disord, 2016, 18:315-323.
[33] Kelley SA, Robinson S, Crone NE, Soares BP. Bottom-of-sulcus focal cortical dysplasia presenting as epilepsia partialis continua multimodality characterization including 7T MRI[J]. Childs Nerv Syst, 2018, 34:1267-1269.
[34] Colombo N, Tassi L, Deleo F, Citterio A, Bramerio M, Mai R, Sartori I, Cardinale F, Lo Russo G, Spreafico R. Focal cortical dysplasia type Ⅱa andⅡb:MRI aspects in 118 cases proven by histopathology[J]. Neuroradiology, 2012, 54:1065-1077.
[35] Zucca I, Milesi G, Medici V, Tassi L, Didato G, Cardinale F, Tringali G, Colombo N, Bramerio M, D'Incerti L, Freri E, Morbin M, Fugnanesi V, Figini M, Spreafico R, Garbelli R. Type Ⅱ focal cortical dysplasia:ex vivo 7T magnetic resonance imaging abnormalities and histopathological comparisons[J]. Ann Neurol, 2016, 79:42-58.
[36] Bartolini E, Cosottini M, Costagli M, Barba C, Tassi L, Spreafico R, Garbelli R, Biagi L, Buccoliero A, Giordano F, Guerrini R. Ultra-high-field targeted imaging of focal cortical dysplasia:the intracortical black line sign in type Ⅱ b[J]. AJNR Am J Neuroradiol, 2019, 40:2137-2142.
[37] Tang Y, Blumcke I, Su TY, Choi JY, Krishnan B, Murakami H, Alexopoulos AV, Najm IM, Jones SE, Wang ZI. Black line sign in focal cortical dysplasia Ⅱ B:a 7T MRI and electro-clinico-pathologic study[J]. Neurology, 2022[.Epub ahead of print]
[38] De Ciantis A, Barkovich AJ, Cosottini M, Barba C, Montanaro D, Costagli M, Tosetti M, Biagi L, Dobyns WB, Guerrini R. Ultra-high -field MR imaging in polymicrogyria and epilepsy[J]. AJNR Am J Neuroradiol, 2015, 36:309-316.
[39] Lampinen B, Zampeli A, Björkman-Burtscher IM, Szczepankiewicz F, Källén K, Compagno Strandberg M, Nilsson M. Tensor-valued diffusion MRI differentiates cortex and white matter in malformations of cortical development associated with epilepsy[J]. Epilepsia, 2020, 61:1701-1713.
[40] Sun K, Cui J, Wang B, Jiang T, Chen Z, Cong F, Zhuo Y, Liang S, Xue R, Yu X, Chen L. Magnetic resonance imaging of tuberous sclerosis complex with or without epilepsy at 7T[J]. Neuroradiology, 2018, 60:785-794.
[41] Wang ZI, Oh SH, Lowe M, Larvie M, Ruggieri P, Hill V, Statsevych V, Moon D, Lee J, Emch T, Bena J, Blümcke I, Bingaman W, Gonzalez-Martinez JA, Najm I, Jones SE. Radiological and clinical value of 7T MRI for evaluating 3T-visible lesions in pharmacoresistant focal epilepsies[J]. Front Neurol, 2021, 12:591586.
[42] Opheim G, van der Kolk A, Markenroth Bloch K, Colon AJ, Davis KA, Henry TR, Jansen JFA, Jones SE, Pan JW, Rössler K, Stein JM, Strandberg MC, Trattnig S, Van de Moortele PF, Vargas MI, Wang I, Bartolomei F, Bernasconi N, Bernasconi A, Bernhardt B, Björkman-Burtscher I, Cosottini M, Das SR, Hertz-Pannier L, Inati S, Jurkiewicz MT, Khan AR, Liang S, Ma RE, Mukundan S, Pardoe H, Pinborg LH, Polimeni JR, Ranjeva JP, Steijvers E, Stufflebeam S, Veersema TJ, Vignaud A, Voets N, Vulliemoz S, Wiggins CJ, Xue R, Guerrini R, Guye M. 7T epilepsy task force consensus recommendations on the use of 7T MRI in clinical practice[J]. Neurology, 2021, 96:327-3

Please choose a citation manager

Content to export